Authors: Zauner, W Lingnau, K Mattner, F von Gabain, A Buschle, M

Citation: W. Zauner et al., Defined synthetic vaccines, BIOL CHEM, 382(4), 2001, pp. 581-595

Authors: Finotto, S Buerke, M Lingnau, K Schmitt, E Galle, PR Neurath, MF

Citation: S. Finotto et al., Local administration of antisense phosphorothioate oligonucleotides to thec-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma, J ALLERG CL, 107(2), 2001, pp. 279-286

Authors: Walter, W Scheuer, C Lingnau, K Reichert, TE Schmitt, E Loos, M Maeurer, MJ

Citation: W. Walter et al., H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines, IMMUNOGENET, 51(10), 2000, pp. 794-804

Authors: Muller, G Muller, A Jonuleit, H Steinbrink, K Szalma, C Paragnik, L Lingnau, K Schmidt, E Knop, J Enk, AH

Citation: G. Muller et al., Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches, J INVES DER, 114(1), 2000, pp. 142-148

Authors: Walter, W Lingnau, K Schmitt, E Loos, M Maeurer, MJ

Citation: W. Walter et al., MHC class II antigen presentation pathway in marine tumours: tumour evasion from immunosurveillance?, BR J CANC, 83(9), 2000, pp. 1192-1201